Two Sigma Ventures is an early-stage venture capital fund that invests in companies run by highly driven people.
Two Sigma Ventures is an early-stage venture capital fund based in New York City investing capital and expertise in entrepreneurs leveraging data and computing to create the future. In partnership with our parent company, Two Sigma Investments, we provide entrepreneurs access to a proprietary network of experts and startup resources to give them a competitive edge.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 21, 2022
Enveda Biosciences
|
Series B | $55M | Biotechnology | — |
Nov 29, 2022
Cajal Neuroscience
|
Series A | $96M | Biotechnology | — |
Jul 13, 2022
Xilis
|
Series A | $19M | Biotechnology | — |
May 18, 2022
Isabl Inc.
|
Seed | $3M | Biotechnology | Yes |
Apr 11, 2022
Tive
|
Series B | $54M | Enterprise Software | — |